No photo of Marco van de Weert
19962019

Research activity per year

Network

Svend Havelund

  • Novo Nordisk A/S (Biz)

External person

Lorenzo Stella

  • University of Rome Tor Vergata

External person

Wim E Hennink

  • Utrecht University

External person

Simon Bjerregaard

  • Novo Nordisk A/S (Biz)

External person

James M. Flink

  • Novo Nordisk A/S (Biz)

External person

Wim Jiskoot

  • Leiden University

External person

Daan J A Crommelin

  • Utrecht University

External person

Johan Haverkamp

  • Utrecht University

External person

Ron van 't Hof

  • Utrecht University

External person

Per-Olof Wahlund

  • Novo Nordisk A/S (Biz)

External person

Simon Bjerregaard

  • Novo Nordisk A/S (Biz)

External person

Fija M. Lagerwerf

  • Utrecht University

External person

Sara Bobone

  • Universita degli Studi di Roma Tor Vergata

External person

Peter Skagerlind

  • Novozymes A/S

External person

Wigger Heerma

  • Utrecht University

External person

Lars Hovgaard

  • Novo Nordisk A/S (Biz)

External person

Michiel Rijkeboer

  • University of Groningen

External person

Dmitri I. Svergun

  • European Molecular Biology Laboratory, Hamburg

External person

Salvatore Spagnolo

  • Università degli Studi di Palermo

External person

Hanns-Christian Mahler

  • F. Hoffmann-La Roche, Ltd

External person

Henrik Parshad

  • Novo Nordisk A/S (Biz)

External person

Qi Zhou

  • Zhejiang University
  • University of Vienna

External person

B. Sarmento

  • University of Porto

External person

J.F.W. Nijsen

  • Utrecht University

External person

Joerg H. O. Garbe

  • F. Hoffmann-La Roche Ltd

External person

Ronald Isaksson

  • Kalmar Universitet

External person

Jes Kristian Jacobsen

  • Novo Nordisk A/S (Biz)

External person

Wim E. Hennink

  • Utrecht University

External person

Ruedeeporn Tantipolphan

  • Leiden University

External person

Jens T. Bukrinsky

  • Novo Nordisk A/S (Biz)

External person

Nanna Aaby Kruse

  • Lægemiddelstyrelsen

External person

Damian Houde

  • Biogen IDEC

External person

Maurizio Leone

  • Università degli Studi di Palermo

External person

Dorte Bjerre Steensgaard

  • Novo Nordisk A/S (Biz)

External person

Robert Barker

  • Institut Max Von Laue Paul Langevin

External person

Marten Klukkert

  • University of Hamburg

External person

L. Lindgaard Hansen

  • Takeda Pharmaceutical Company Limited

External person

Daan J.A. Crommelin

  • Utrecht University

External person

Susana Martins

  • University of Porto

External person

Wim E. Hennink

  • Utrecht University

External person

Sarah Hook

  • Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland

External person

Henderik W. Frijlink

  • University of Groningen

External person

George Posthuma

  • Utrecht University

External person

Daan J.A. Crommelin

  • Utrecht University

External person

Anders D. Nielsen

  • Novo Nordisk A/S (Biz)

External person

A. de Witte

  • Utrecht University

External person

Mikael Nilsson

  • Kalmar Universitet

External person

Henrik Parshad

  • Novo Nordisk A/S (Biz)

External person

H. Yamamoto

  • Gifu Pharmaceutical University

External person

Anders Nielsen

  • Novo Nordisk A/S (Biz)

External person

James M. Flink

  • Novo Nordisk A/S (Biz)

External person

Hugh D. Burrows

  • University of Coimbra

External person

Jes K. Jacobsen

  • Novo Nordisk A/S (Biz)

External person

Theodore W. Randolph

  • University of Colorado Boulder

External person

Fabio Librizzi

  • Università degli Studi di Palermo

External person

B. Fabi

  • Protein Chemistry Department

External person

H. Talsma

  • Utrecht University

External person

S. Lemoult

  • Protein Chemistry Department

External person

Fabio Librizzi

  • Università degli Studi di Palermo

External person

Claudia S Leopold

  • University of Hamborg
  • University of Hamburg

External person

Anna J Svagan

  • Kobenhavns Universitet

External person

Tudor Arvinte

  • University of Geneva

External person

João Pinto

  • NOVA University Lisbon

External person

Wouter L. J. Hinrichs

  • University of Groningen

External person

Wim Jiskoot

  • UIPS
  • Leiden University

External person

Manuel A. Méndez

  • Ecole Polytechnique Féderal de Lausanne

External person

Maria Anderot

  • Kalmar Universitet

External person

Ron M.A. Heeren

  • AMOLF
  • Maastricht University

External person

Devendra S Kalonia

  • University of Connecticut

External person

Hubert H. Girault

  • Ecole Polytechnique Féderal de Lausanne

External person

H. Takeuchi

  • Gifu Pharmaceutical University

External person

Joachim A. Hering

  • De Montfort University

External person

Marc Sutter

  • Division of drug delivery technology, Leiden/LACDR

External person

Charlotte Vermehren

  • LiPlasome Pharma A/S

External person

Gerd Schluckebier

  • Novo Nordisk A/S (Biz)
  • Novo Nordisk Foundation

External person

Peter Kingshott

  • Forskningscenter Risø

External person

Julia Hoechstetter

  • Utrecht University

External person

Ákos Végvári

  • Uppsala University

External person

P.P. van Rijk

  • Utrecht University

External person

Valeria Vetri

  • Università degli Studi di Palermo

External person

Bjarni Jóhann Vilhjálmsson

  • Aarhus Universitet
  • Kobenhavns Universitet

External person

Gerrit S. Zijlstra

  • University of Groningen

External person

Wim E. Hennink

  • Utrecht University

External person

Y. Kawashima

  • Aichi Gakuin University
  • Gifu Pharmaceutical University

External person

Dirk Jan van Drooge

  • University of Groningen

External person

Wim Jiskoot

  • Leiden/Amsterdam Center for Drug Research

External person

Ben J Boyd

  • Drug Delivery, Disposition and Dynamics, Faculty of Pharmacy and Pharmaceutical Sciences, Monash university

External person

A.D. van het Schip

  • Utrecht University

External person

Manfred Roessle

  • European Molecular Biology Laboratory, Heidelberg

External person

Rui Fausto

  • University of Coimbra

External person

Anders D Nielsen

  • Novo Nordisk A/S (Biz)

External person

D. C. Ferreira

  • University of Porto

External person

Mathias Norrman

  • Novo Nordisk A/S (Biz)
  • Novo Nordisk Foundation

External person

S. Sønderkær

  • University of Copenhagen

External person

N. Roest

  • Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen

External person

L.M.J. Kroon-Batenburg

  • Utrecht University

External person

Maurizio Leone

  • Università degli Studi di Palermo

External person

M.J. van Steenbergen

  • Utrecht University

External person

Anja Boisen

  • Danmarks Tekniske Universitet

External person

Hans Hoogland

  • LEO Pharma AS

External person

W.E. Hennink

  • Utrecht University

External person

S. Velaga

  • Luleå University of Technology

External person

H. Kooijman

  • Utrecht University

External person

Michael Wiggenhorn

  • Coriolis Pharma

External person

Parvez I. Haris

  • De Montfort University

External person

Dmitri I. Svergun

  • European Molecular Biology Laboratory, Heidelberg

External person

Andrea Hawe

  • Leiden/Amsterdam Center for Drug Research

External person

Antti Poso

  • University of Eastern Finland

External person

Wim Jiskoot

  • Utrecht University

External person